Alithea Genomics raised €3.3M in a Seed round in Mar 2026. The company is based in Lausanne, Switzerland. Investors in the round: Genku Ventures, Novalis Biotech, Zürcher Kantonalbank. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
